Page 2 - Henry Gosebruch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Henry gosebruch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Henry Gosebruch Today - Breaking & Trending Today

Tracking 2023's Largest IPOs: Instacart, Arm, Klaviyo and More (Updated Sept.)

The U.S. IPO market is slowly waking up from an 18-month pause. Here are the largest listings you need to know. ....

United States , Republic Of , Brandon Leonardo , Dimitri Moshovitis , Shaoqing Xiang , Andrew Bialecki , Daniel Sundheim , Kai Sun , Theodore Xenohristos , Mark Walsh , Howard Wagner , Rene Haas , Thuy Le , Apoorva Mehta , Stephen Williams , Sissi Cao , Yifan Li , Brett Schulman , Lorenzo Dominique Berho Carranza , Henry Gosebruch , Thibaut Mongon , Pham Nhat Vuong , Ike Grigoropoulos , Ed Hallen , Paul Berns , Carol Suh ,

Neumora seeks to become the second Massachusetts biotech to go public in 2023

Neumora hopes to raise up to $265 million from investors, leaving it with a market value of as much as $2.7 billion. ....

United States , United Kingdom , Ben Bradford , Matt Kennedy , Henry Gosebruch , Exchange Commission , Drug Administration , Massachusetts Biotechnology Council , Renaissance Capital , Sage Therapeutics , Arch Venture Partners ,

SoftBank-backed biopharma firm Neumora Therapeutics files for US IPO

The filing comes at a time of renewed investor interest in IPOs following a flurry of deals in the United States and European markets ....

United States , New York , Paul Berns , Henry Gosebruch , Neumora Therapeutics , Arch Venture Partners ,

(Reuters) Neumora Therapeutics, a biopharmaceutical firm backed by biotech Amgen and Japan's SoftBank, on Friday filed for an initial public offeri ....

United States , New York , Henry Gosebruch , Paul Berns , Arch Venture Partners , Neumora Therapeutics , Softbank Backed ,

SoftBank-backed Neumora Therapeutics files paperwork for U.S. IPO

(Reuters) -Neumora Therapeutics, a biopharmaceutical firm backed by biotech Amgen and Japan's SoftBank, on Friday filed for an initial public offering. ....

New York , United States , Paul Berns , Jaiveer Singh Shekhawat , Henry Gosebruch , Leroy Leo , Shailesh Kuber , Neumora Therapeutics , Arch Venture Partners ,